INS and polyneuropathy: The lowered blood glucose level rather than the insulin dose was related to reduced mortality (p < 0.0001), critical illness polyneuropathy (p < 0.0001), bacteremia (p = 0.02), and inflammation (p = 0.0006) but not to prevention of acute renal failure.